Latex Agglutination Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global latex agglutination test market is poised for substantial growth in the coming decade. According to a recent report by Fairfield Market Research, the market is estimated to have reached approximately US$ 2.8 billion in revenue for the year 2024. The impressive growth trajectory is attributed to several key factors, including the rapidly increasing adoption of latex agglutination tests (LAT) across various healthcare settings.

Rapid Adoption of LAT in Healthcare Settings

Latex agglutination tests have become indispensable tools in the prevention and monitoring of hospital-acquired infections, particularly those caused by staphylococcus aureus (S. aureus). The Centers for Disease Control and Prevention (CDC) reports that one in 31 hospital patients experiences at least one infection related to their medical care daily. Given the higher susceptibility of patients in healthcare settings to staph infections, especially in intensive care units (ICUs) and among those with medical devices, the need for LAT to monitor bacterial loads, including S. aureus, is paramount.

Challenges in Latex Agglutination Testing

Despite its widespread use, latex agglutination testing does pose certain challenges. The reaction time analysis is critical, as immunoagglutination assays do not reach a distinct endpoint. Over time, particles settle, and liquid dries, making result interpretation more challenging and potentially leading to false-positive results. The need for trained professionals to accurately grade the assay as strong, intermediate, or weak positive is essential.

Moreover, more advanced tests like enzyme-linked immunosorbent assays (ELISAs) and chemiluminescence immunoassays offer advantages in terms of accuracy and timeliness compared to LAT. This competition from alternative testing methods could restrain market growth.

Surging Demand in the U.S. Market

The United States is witnessing a surge in the demand for latex agglutination tests due to the rise in infectious diseases. According to the CDC, in 2018, 3.4 million patients visited emergency departments in the U.S. with infectious diseases and parasitic diseases as their primary diagnosis. This high caseload necessitates increased testing for early diagnosis and treatment, driving the growth of the latex agglutination test market.

Thriving Market in Germany

Germany stands as a prominent hub for research and development in education, business, and training. In 2020, the European Union invested nearly 310 billion euros in the R&D sector, leading to greater technology utilization in clinical diagnostics and immunoassays for medical purposes. As a result, the market for latex agglutination is flourishing in Germany.

Emergence of China as a Key Market

China, with its vast population and significant animal population, faces unique healthcare challenges. S. aureus, the most prevalent Gram-positive bacteria in China, causes a wide range of clinical infections. China's ecosystem poses risks for rare, emerging, and developing diseases, making the country a prominent market for latex agglutination products.

Competitive Landscape Analysis

Leading manufacturers in the latex agglutination sector are continuously innovating to expand their product lines. Several major competitors have engaged in consolidation efforts to advance research and development, ensuring they stay at the forefront of this dynamic market.

Key Companies in the Latex Agglutination Test Market

Atlas Medical GmbH
Thermo Fisher Scientific
Cardinal Health
Mira Vista Labs
Lorne Laboratories Limited
Bio-Rad Laboratories, Inc.
Calbiotech
Eurofins Technologies
Beckman Coulter, Inc.
Hardy Diagnostics
Geneilabs
Mast Group Ltd.
Lab Care Diagnostics (India) Pvt. Ltd.
Ngaio Diagnostics
ARKRAY, Inc.
bioMerieux SA
Creative Diagnostics
HiMedia Laboratories
Biotec

The future of the latex agglutination test market looks promising, driven by the increasing need for infection control and diagnosis in healthcare settings worldwide.

1. Executive Summary

1.1. Global Latex Agglutination Test Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Latex Agglutination Test Market Outlook, 2018 - 2031

3.1. Global Latex Agglutination Test Market Outlook, by Test Type, Value (US$ Mn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. LAT for Antigen Detection
  - 3.1.1.2. LAT for Antibody Detection
3.2. Global Latex Agglutination Test Market Outlook, by Sample Type, Value (US$ Mn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Blood/Plasma
  - 3.2.1.2. Cerebrospinal Fluid (CSF)
  - 3.2.1.3. Urine
  - 3.2.1.4. Sperm
  - 3.2.1.5. Others
3.3. Global Latex Agglutination Test Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Diagnostics
    - 3.3.1.1.1. Human Use
    - 3.3.1.1.2. Veterinary Use
  - 3.3.1.2. Research Use
3.4. Global Latex Agglutination Test Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Hospitals
  - 3.4.1.2. Diagnostic laboratories
  - 3.4.1.3. Academic & Research Institutes
3.5. Global Latex Agglutination Test Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Latex Agglutination Test Market Outlook, 2018 - 2031

4.1. North America Latex Agglutination Test Market Outlook, by Test Type, Value (US$ Mn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. LAT for Antigen Detection
  - 4.1.1.2. LAT for Antibody Detection
4.2. North America Latex Agglutination Test Market Outlook, by Sample Type, Value (US$ Mn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Blood/Plasma
  - 4.2.1.2. Cerebrospinal Fluid (CSF)
  - 4.2.1.3. Urine
  - 4.2.1.4. Sperm
  - 4.2.1.5. Others
4.3. North America Latex Agglutination Test Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Diagnostics
    - 4.3.1.1.1. Human Use
    - 4.3.1.1.2. Veterinary Use
  - 4.3.1.2. Research Use
4.4. North America Latex Agglutination Test Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Hospitals
  - 4.4.1.2. Diagnostic laboratories
  - 4.4.1.3. Academic & Research Institutes
4.5. North America Latex Agglutination Test Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 4.5.1.2. U.S. Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 4.5.1.3. U.S. Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 4.5.1.4. U.S. Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 4.5.1.5. Canada Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 4.5.1.6. Canada Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 4.5.1.7. Canada Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 4.5.1.8. Canada Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Latex Agglutination Test Market Outlook, 2018 - 2031

5.1. Europe Latex Agglutination Test Market Outlook, by Test Type, Value (US$ Mn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. LAT for Antigen Detection
  - 5.1.1.2. LAT for Antibody Detection
5.2. Europe Latex Agglutination Test Market Outlook, by Sample Type, Value (US$ Mn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Blood/Plasma
  - 5.2.1.2. Cerebrospinal Fluid (CSF)
  - 5.2.1.3. Urine
  - 5.2.1.4. Sperm
  - 5.2.1.5. Others
5.3. Europe Latex Agglutination Test Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Diagnostics
    - 5.3.1.1.1. Human Use
    - 5.3.1.1.2. Veterinary Use
  - 5.3.1.2. Research Use
5.4. Europe Latex Agglutination Test Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Hospitals
  - 5.4.1.2. Diagnostic laboratories
  - 5.4.1.3. Academic & Research Institutes
5.5. Europe Latex Agglutination Test Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.2. Germany Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.3. Germany Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.4. Germany Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.5. U.K. Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.6. U.K. Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.7. U.K. Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.8. U.K. Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.9. France Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.10. France Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.11. France Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.12. France Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.13. Italy Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.14. Italy Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.15. Italy Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.16. Italy Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.17. Turkey Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.18. Turkey Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.19. Turkey Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.20. Turkey Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.21. Russia Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.22. Russia Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.23. Russia Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.24. Russia Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.25. Rest of Europe Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.26. Rest of Europe Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.27. Rest of Europe Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.28. Rest of Europe Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Latex Agglutination Test Market Outlook, 2018 - 2031

6.1. Asia Pacific Latex Agglutination Test Market Outlook, by Test Type, Value (US$ Mn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. LAT for Antigen Detection
  - 6.1.1.2. LAT for Antibody Detection
6.2. Asia Pacific Latex Agglutination Test Market Outlook, by Sample Type, Value (US$ Mn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Blood/Plasma
  - 6.2.1.2. Cerebrospinal Fluid (CSF)
  - 6.2.1.3. Urine
  - 6.2.1.4. Sperm
  - 6.2.1.5. Others
6.3. Asia Pacific Latex Agglutination Test Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Diagnostics
    - 6.3.1.1.1. Human Use
    - 6.3.1.1.2. Veterinary Use
  - 6.3.1.2. Research Use
6.4. Asia Pacific Latex Agglutination Test Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Hospitals
  - 6.4.1.2. Diagnostic laboratories
  - 6.4.1.3. Academic & Research Institutes
6.5. Asia Pacific Latex Agglutination Test Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.2. China Latex Agglutination Test Market Sample Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.3. China Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.4. China Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.5. Japan Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.6. Japan Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.7. Japan Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.8. Japan Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.9. South Korea Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.10. South Korea Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.11. South Korea Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.12. South Korea Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.13. India Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.14. India Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.15. India Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.16. India Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.17. Southeast Asia Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.18. Southeast Asia Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.19. Southeast Asia Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.20. Southeast Asia Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Latex Agglutination Test Market Outlook, 2018 - 2031

7.1. Latin America Latex Agglutination Test Market Outlook, by Test Type, Value (US$ Mn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. LAT for Antigen Detection
  - 7.1.1.2. LAT for Antibody Detection
7.2. Latin America Latex Agglutination Test Market Outlook, by Sample Type, Value (US$ Mn), 2018 - 2031
7.3. Latin America Latex Agglutination Test Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Diagnostics
    - 7.3.1.1.1. Human Use
    - 7.3.1.1.2. Veterinary Use
  - 7.3.1.2. Research Use
7.4. Latin America Latex Agglutination Test Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Hospitals
  - 7.4.1.2. Diagnostic laboratories
  - 7.4.1.3. Academic & Research Institutes
7.5. Latin America Latex Agglutination Test Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.2. Brazil Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.3. Brazil Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.5.1.4. Brazil Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.5.1.5. Mexico Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.6. Mexico Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.7. Mexico Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.5.1.8. Mexico Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.5.1.9. Argentina Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.10. Argentina Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.11. Argentina Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.5.1.12. Argentina Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Latex Agglutination Test Market Outlook, 2018 - 2031

8.1. Middle East & Africa Latex Agglutination Test Market Outlook, by Test Type, Value (US$ Mn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. LAT for Antigen Detection
  - 8.1.1.2. LAT for Antibody Detection
8.2. Middle East & Africa Latex Agglutination Test Market Outlook, by Sample Type, Value (US$ Mn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Blood/Plasma
  - 8.2.1.2. Cerebrospinal Fluid (CSF)
  - 8.2.1.3. Urine
  - 8.2.1.4. Sperm
  - 8.2.1.5. Others
8.3. Middle East & Africa Latex Agglutination Test Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Diagnostics
    - 8.3.1.1.1. Human Use
    - 8.3.1.1.2. Veterinary Use
  - 8.3.1.2. Research Use
8.4. Middle East & Africa Latex Agglutination Test Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Hospitals
  - 8.4.1.2. Diagnostic laboratories
  - 8.4.1.3. Academic & Research Institutes
8.5. Middle East & Africa Latex Agglutination Test Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.2. GCC Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.3. GCC Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.4. GCC Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.5. South Africa Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.6. South Africa Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.7. South Africa Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.8. South Africa Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.9. Egypt Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.10. Egypt Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.11. Egypt Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.12. Egypt Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.13. Nigeria Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.14. Nigeria Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.15. Nigeria Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.16. Nigeria Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Latex Agglutination Test Market by Test Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Latex Agglutination Test Market by Sample Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Latex Agglutination Test Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Latex Agglutination Test Market by End User, Value (US$ Mn), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. by Application vs by Sample Type Heatmap
9.2. Manufacturer vs by Sample Type Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Thermo Fisher Scientific
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. bioMerieux SA
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Mira Vista Labs
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Lorne Laboratories Limited
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Bio-Rad Laboratories, Inc.
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Calbiotech
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Eurofins Technologies
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Beckman Coulter, Inc.
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Hardy Diagnostics
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Geneilabs
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development
- 9.5.11. Mast Group Ltd.
  - 9.5.11.1. Company Overview
  - 9.5.11.2. Product Portfolio
  - 9.5.11.3. Financial Overview
  - 9.5.11.4. Business Strategies and Development
- 9.5.12. Lab Care Diagnostics (India) Pvt. Ltd.
  - 9.5.12.1. Company Overview
  - 9.5.12.2. Product Portfolio
  - 9.5.12.3. Financial Overview
  - 9.5.12.4. Business Strategies and Development
- 9.5.13. Ngaio Diagnostics
  - 9.5.13.1. Company Overview
  - 9.5.13.2. Product Portfolio
  - 9.5.13.3. Financial Overview
  - 9.5.13.4. Business Strategies and Development
- 9.5.14. ARKRAY, Inc.
  - 9.5.14.1. Company Overview
  - 9.5.14.2. Product Portfolio
  - 9.5.14.3. Financial Overview
  - 9.5.14.4. Business Strategies and Development
- 9.5.15. Cardinal Health
  - 9.5.15.1. Company Overview
  - 9.5.15.2. Product Portfolio
  - 9.5.15.3. Financial Overview
  - 9.5.15.4. Business Strategies and Development
- 9.5.16. Creative Diagnostics
  - 9.5.16.1. Company Overview
  - 9.5.16.2. Product Portfolio
  - 9.5.16.3. Financial Overview
  - 9.5.16.4. Business Strategies and Development
- 9.5.17. HiMedia Laboratories
  - 9.5.17.1. Company Overview
  - 9.5.17.2. Product Portfolio
  - 9.5.17.3. Financial Overview
  - 9.5.17.4. Business Strategies and Development
- 9.5.18. Biotec
  - 9.5.18.1. Company Overview
  - 9.5.18.2. Product Portfolio
  - 9.5.18.3. Financial Overview
  - 9.5.18.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations